Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesDividends payablesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

LifeMD (LFMDP) Current Deferred Revenue (2018 - 2025)

Historic Current Deferred Revenue for LifeMD (LFMDP) over the last 8 years, with Q3 2025 value amounting to $14.4 million.

  • LifeMD's Current Deferred Revenue fell 3004.86% to $14.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $14.4 million, marking a year-over-year decrease of 3004.86%. This contributed to the annual value of $19.6 million for FY2024, which is 10209.37% up from last year.
  • LifeMD's Current Deferred Revenue amounted to $14.4 million in Q3 2025, which was down 3004.86% from $11.8 million recorded in Q2 2025.
  • LifeMD's 5-year Current Deferred Revenue high stood at $20.6 million for Q3 2024, and its period low was $1.3 million during Q1 2021.
  • Over the past 5 years, LifeMD's median Current Deferred Revenue value was $5.9 million (recorded in 2023), while the average stood at $8.1 million.
  • In the last 5 years, LifeMD's Current Deferred Revenue skyrocketed by 35507.89% in 2021 and then tumbled by 3004.86% in 2025.
  • LifeMD's Current Deferred Revenue (Quarter) stood at $1.5 million in 2021, then soared by 269.86% to $5.5 million in 2022, then surged by 75.06% to $9.7 million in 2023, then skyrocketed by 102.09% to $19.6 million in 2024, then fell by 26.63% to $14.4 million in 2025.
  • Its Current Deferred Revenue stands at $14.4 million for Q3 2025, versus $11.8 million for Q2 2025 and $14.6 million for Q1 2025.